Skip to main content

Table 1 Clinical and immunohistochemical features of AFX and BFH

From: Mutation analysis of the Gadd45 gene at exon 4 in atypical fibroxanthoma

Lesion

Age/Sex/Location

Bax

Gadd45*

Gadd45 mutation at exon 4

p53*

A3 AFX

82/M/Scalp

-

-

NA

-

A7 AFX

84/M/Face

-

+

-

-

A10 AFX

65/M/Auricle

-

-

-

+

A14 AFX

71/M/Auricle

+

+

-

+

A16 AFX

50/M/Finger

-

-

-

-

A17 AFX

46/M/Finger

+

+

-

-

A19 AFX

64/F/Leg

+

+

-

-

B8 BFH

18/F/Thigh

-

-

NA

-

B9 BFH

38/F/Back

-

-

NA

-

B12 BFH

32/M/Thigh

-

-

NA

-

B13 BFH

35/F/Leg

-

+

NA

-

B16 BFH

30/F/Chest wall

-

-

NA

-

B17 BFH

23/M/Forearm

-

-

NA

-

B21 BFH

31/F/Leg

-

-

NA

-

  1. AFX, atypical fibroxanthoma; BFH, benign fibrous histiocytoma (BFHs were selected at random from our histological files); *, data were reported previously; NA, not assessed.